Journal of Antimicrobial Chemotherapy

Glycodendritic structures: promising new antiviral drugs
pp. 579-581(3)
Authors: Javier Rojo; Rafael Delgado

Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity
pp. 582-586(5)
Authors: Kathryn L. Springer; Adriana Weinberg

The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens
pp. 587-592(6)
Author: Jose R. Arribas

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
pp. 593-602(10)
Authors: Giovanni Di Perri; Stefano Bonora

Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin
pp. 603-608(6)
Authors: Antonella Lupetti; Carlo P. J. M. Brouwer; Heleen E. C. Dogterom-Ballering; Sonia Senesi; Mario Campa; Jaap T. van Dissel; Peter H. Nibbering

In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes
pp. 609-616(8)
Authors: Mirjam Walker; Jean François Rossignol; Paul Torgerson; Andrew Hemphill

Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods
pp. 617-620(4)
Authors: Shazad Mushtaq; Marina Warner; Alan P. Johnson; David M. Livermore

Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica
pp. 621-627(7)
Authors: L. P. Randall; S. W. Cooles; L. J. V. Piddock; M. J. Woodward

Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum -lactamases in York, UK
pp. 628-633(6)
Authors: C. J. Munday; G. M. Whitehead; N. J. Todd; M. Campbell; P. M. Hawkey

Frequency and diversity of Class A extended-spectrum -lactamases in hospitals of the Auvergne, France: a 2 year prospective study
pp. 634-639(6)
Authors: C. De Champs; C. Chanal; D. Sirot; R. Baraduc; J. P. Romaszko; R. Bonnet; A. Plaidy; M. Boyer; E. Carroy; M. C. Gbadamassi; S. Laluque; O. Oules; M. C. Poupart; M. Villemain; J. Sirot

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants
pp. 640-647(8)
Authors: Delphine Croisier; Manuel Etienne; Lionel Piroth; Emilie Bergoin; Catherine Lequeu; Henri Portier; Pascal Chavanet

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
pp. 648-653(6)
Authors: Danuta Kruszewska; Hans-Georg Sahl; Gabriele Bierbaum; Ulrike Pag; Sean O. Hynes; Åsa Ljungh

Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models
pp. 654-660(7)
Authors: Andrea Giacometti; Roberto Ghiselli; Oscar Cirioni; Federico Mocchegiani; Giuseppina D'Amato; Fiorenza Orlando; Valerio Sisti; Wojciech Kamysz; Carmela Silvestri; Piotr Naldoski; Jerzy ukasiak; Vittorio Saba; Giorgio Scalise

Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial
pp. 661-672(12)
Authors: Samuel Coenen; Paul Van Royen; Barbara Michiels; Joke Denekens

Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?
pp. 673-679(7)
Authors: Yanina Balabanova; Ivan Fedorin; Sergey Kuznetsov; Catriona Graham; Michael Ruddy; Rifat Atun; Richard Coker; Francis Drobniewski

Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon
pp. 680-683(4)
Authors: David A. Boyd; Pamela Kibsey; Diane Roscoe; Michael R. Mulvey

Phenotypic detection of extended-spectrum and AmpC -lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test
pp. 684-687(4)
Authors: M. Shahid; Abida Malik; Mithlesh Agrawal; Sanjay Singhal

Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica
pp. 688-691(4)
Authors: L. P. Randall; S. W. Cooles; L. J. V. Piddock; M. J. Woodward

Comment on: Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig
pp. 692-693(2)
Authors: Peter Silley; Robrecht Froyman

Reply
pp. 693-694(2)
Authors: Anne A. Delsol; Martin J. Woodward; John M. Roe

Reply
pp. 694-695(2)
Authors: David R. Bangsberg; Andrew R. Moss; Steven G. Deeks

There are no paradoxes of adherence and drug resistance to HIV antiretroviral therapy
pp. 694-694(1)
Author: David A. Green

Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin
pp. 695-696(2)
Authors: Ahmed Hamouda; Sebastian G. B. Amyes

Susceptibility of capsular Staphylococcus aureus strains to some antibiotics, triclosan and cationic biocides
pp. 696-698(3)
Authors: Paul Seaman; Martin Day; A. Denver Russell; Dietmar Ochs

BSAC Respiratory Resistance Surveillance Programme (2002–2003): comparative susceptibility of Streptococcus pneumoniae, cultured from patients in Great Britain and Ireland with community-acquired lower respiratory tract infection, to gemifloxacin
pp. 698-699(2)
Authors: David Felmingham; Jemma Shackcloth; Glenn Tillotson

Emergence of IMP-4 metallo--lactamase in a clinical isolate from Australia
pp. 699-700(2)
Authors: Anton Y. Peleg; Clare Franklin; Jan Bell; Denis W. Spelman